Accelmed Partners II L.P. 13D/13G Filings for NeuroPace, Inc. (NPCE)

Accelmed Partners II L.P. 13D and 13G filings for NeuroPace, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-11-23
5:11 pm
Purchase		 2022-11-21 13D NeuroPace, Inc.
NPCE		 Accelmed Partners II L.P. 4,432,948
17.800%		 390,291increase
(+9.65%)		 Filing
2022-11-21
07:00 am
Purchase		 2022-11-18 13D NeuroPace, Inc.
NPCE		 Accelmed Partners II L.P. 4,042,657
16.200%		 4,042,657increase
(New Position)		 Filing